These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 17162154

  • 1. Rituximab therapy for Epstein-Barr virus-related chronic hepatitis following living donor kidney transplantation.
    Ohta K, Shimizu M, Nakai A, Toma T, Kasahara Y, Arii C, Yachie A, Kawamura T, Aikawa A, Hasegawa A, Sato K, Yokoyama H, Ishikawa I, Koizumi S.
    Am J Kidney Dis; 2006 Dec; 48(6):986-9. PubMed ID: 17162154
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Post-transplant lymphoproliferative disease and other Epstein-Barr virus diseases in allogeneic haematopoietic stem cell transplantation after introduction of monitoring of viral load by polymerase chain reaction.
    Kinch A, Oberg G, Arvidson J, Falk KI, Linde A, Pauksens K.
    Scand J Infect Dis; 2007 Dec; 39(3):235-44. PubMed ID: 17366054
    [Abstract] [Full Text] [Related]

  • 7. Epstein-Barr virus hepatitis: diagnostic value of in situ hybridization, polymerase chain reaction, and immunohistochemistry on liver biopsy from immunocompetent patients.
    Suh N, Liapis H, Misdraji J, Brunt EM, Wang HL.
    Am J Surg Pathol; 2007 Sep; 31(9):1403-9. PubMed ID: 17721196
    [Abstract] [Full Text] [Related]

  • 8. Preemptive management of Epstein-Barr virus reactivation after hematopoietic stem-cell transplantation.
    Ahmad I, Cau NV, Kwan J, Maaroufi Y, Meuleman N, Aoun M, Lewalle P, Martiat P, Crokaert F, Bron D.
    Transplantation; 2009 Apr 27; 87(8):1240-5. PubMed ID: 19384173
    [Abstract] [Full Text] [Related]

  • 9. [Allogeneic peripheral blood stem cell transplantation for a hepatitis B virus carrier with Epstein-Barr virus associated with hemophagocytic syndrome].
    Sakai R, Maruta A, Yamazaki E, Kamijo A, Taguchi J, Hyo R, Tanaka M, Fujimaki K, Nagao T, Yoshiba M, Ishigatsubo Y.
    Rinsho Ketsueki; 2004 May 27; 45(5):397-401. PubMed ID: 15199750
    [Abstract] [Full Text] [Related]

  • 10. Monitoring of Epstein-Barr virus load after hematopoietic stem cell transplantation for early intervention in post-transplant lymphoproliferative disease.
    Meerbach A, Wutzler P, Häfer R, Zintl F, Gruhn B.
    J Med Virol; 2008 Mar 27; 80(3):441-54. PubMed ID: 18205222
    [Abstract] [Full Text] [Related]

  • 11. Low viral load post-transplant lymphoproliferative disease localized within the tongue.
    Henry DD, Hunger SP, Braylan RC, Dharnidharka VR.
    Transpl Infect Dis; 2008 Dec 27; 10(6):426-30. PubMed ID: 18657087
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Successful control of Epstein-Barr virus (EBV)-infected cells by allogeneic nonmyeloablative stem cell transplantation in a patient with the lethal form of chronic active EBV infection.
    Uehara T, Nakaseko C, Hara S, Harima A, Ejiri M, Yokota A, Saito Y, Nishimura M.
    Am J Hematol; 2004 Aug 27; 76(4):368-72. PubMed ID: 15282671
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Elevation of Epstein-Barr virus (EBV)-DNA in the peripheral blood of a patient with age-related EBV-associated B-cell lymphoproliferative disorder].
    Tanioka R, Mori S, Nakanishi T, Fujita S, Nakamichi N, Tajima K, Uemura Y, Amakawa R, Kishimoto Y, Fukuhara S.
    Rinsho Ketsueki; 2007 Nov 27; 48(11):1492-7. PubMed ID: 18080508
    [Abstract] [Full Text] [Related]

  • 17. Successful treatment of EBV PTLD with CNS lymphomas with the monoclonal anti-CD20 antibody rituximab.
    Kordelas L, Trenschel R, Koldehoff M, Elmaagacli A, Beelen DW.
    Onkologie; 2008 Dec 27; 31(12):691-3. PubMed ID: 19060508
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Use of rituximab in conjunction with immunosuppressive chemotherapy as a novel therapy for Epstein Barr virus-associated hemophagocytic lymphohistiocytosis.
    Balamuth NJ, Nichols KE, Paessler M, Teachey DT.
    J Pediatr Hematol Oncol; 2007 Aug 27; 29(8):569-73. PubMed ID: 17762500
    [Abstract] [Full Text] [Related]

  • 20. Association between elevated whole blood Epstein-Barr virus (EBV)-encoded RNA EBV polymerase chain reaction and reduced incidence of acute lung allograft rejection.
    Ahya VN, Douglas LP, Andreadis C, Arnoldi S, Svoboda J, Kotloff RM, Hadjiliadis D, Sager JS, Woo YJ, Pochettino A, Schuster SJ, Stadtmauer EA, Tsai DE.
    J Heart Lung Transplant; 2007 Aug 27; 26(8):839-44. PubMed ID: 17692789
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.